Immune regulation of metastasis: mechanistic insights and therapeutic opportunities

被引:105
作者
Blomberg, Olga S. [1 ]
Spagnuolo, Lorenzo [1 ]
de Visser, Karin E. [1 ]
机构
[1] Netherlands Canc Inst, Oncode Inst, Div Tumor Biol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
基金
瑞士国家科学基金会; 欧洲研究理事会;
关键词
Metastasis; Inflammation; Immunotherapy; (Pre-)metastatic niche; CIRCULATING TUMOR-CELLS; BREAST-CANCER METASTASIS; NATURAL-KILLER-CELLS; CD4(+) T-CELLS; BONE-MARROW; DENDRITIC CELLS; NECROSIS-FACTOR; MACROPHAGE POLARIZATION; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODY;
D O I
10.1242/dmm.036236
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Metastatic disease is the leading cause of death in cancer patients. Metastasis formation involves a cascade of events for which the underlying mechanisms are still poorly understood. During the metastatic cascade, cancer cells tightly interact with the immune system and they influence each other, both in the tumor microenvironment and systemically. The crosstalk between cancer and immune cells adds another layer of complexity to our understanding of metastasis formation, but at the same time new therapeutic opportunities for cancer patients. The intensifying development of immunotherapeutic strategies calls for a better understanding of immune regulation of metastasis in order to maximize the therapeutic benefit for patients with metastatic disease. In this Review and accompanying poster, we describe the main mechanisms of immune regulation of metastasis that have been reported to date, and present promising immunotherapeutic options that are currently available, or may become so in the near future, to tackle metastasis.
引用
收藏
页数:12
相关论文
共 197 条
[1]   Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment [J].
Acuff, HB ;
Carter, KJ ;
Fingleton, B ;
Gorden, DL ;
Matrisian, LM .
CANCER RESEARCH, 2006, 66 (01) :259-266
[2]   IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients [J].
Ahmadzadeh, M ;
Rosenberg, ST .
BLOOD, 2006, 107 (06) :2409-2414
[3]  
Alexander Walter, 2016, P T, V41, P185
[4]   Lymphangiogenesis in development and human disease [J].
Alitalo, K ;
Tammela, T ;
Petrova, TV .
NATURE, 2005, 438 (7070) :946-953
[5]  
Almand B, 2000, CLIN CANCER RES, V6, P1755
[6]   FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis [J].
Andreu, Pauline ;
Johansson, Magnus ;
Affara, Nesrine I. ;
Pucci, Ferdinando ;
Tan, Tingting ;
Junankar, Simon ;
Korets, Lidiya ;
Lam, Julia ;
Tawfik, David ;
DeNardo, David G. ;
Naldini, Luigi ;
de Visser, Karin E. ;
De Palma, Michele ;
Coussens, Lisa M. .
CANCER CELL, 2010, 17 (02) :121-134
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   B regulatory cells in cancer [J].
Balkwill, Frances ;
Montfort, Anne ;
Capasso, Melanie .
TRENDS IN IMMUNOLOGY, 2013, 34 (04) :169-173
[9]   CSF1R-dependent myeloid cells are required for NK-mediated control of metastasis [J].
Beffinger, Michal ;
Tallon de Lara, Paulino ;
Tugues, Sonia ;
Vermeer, Marijne ;
Montagnolo, Yannick ;
Ohs, Isabel ;
Cecconi, Virginia ;
Lucchiari, Giulia ;
Gagliardi, Aron ;
Misljencevic, Nikola ;
Sutton, James ;
Spoerri, Roman ;
Becher, Burkhard ;
Gupta, Anurag ;
van den Broek, Maries .
JCI INSIGHT, 2018, 3 (10)
[10]  
BENYON RC, 1991, J IMMUNOL, V147, P2253